Recommended Insulin Dosing Schedule for Patients Requiring Insulin Therapy
The recommended insulin dosing schedule for patients requiring insulin therapy is a basal-bolus approach, with basal insulin given once or twice daily along with rapid-acting insulin before meals, plus corrective doses of rapid-acting insulin as needed. 1
Initial Insulin Dosing
For Insulin-Naïve Patients with Type 2 Diabetes:
- Start with basal insulin at 10 units per day or 0.1-0.2 units/kg/day 1, 2
- Set fasting plasma glucose target and choose an evidence-based titration algorithm 1
- Increase dose by 2 units every 3 days to reach fasting glucose target without hypoglycemia 1
- For hypoglycemia: determine cause; if no clear reason, lower dose by 10-20% 1
For Patients with Type 1 Diabetes:
- Approximately one-third of total daily insulin requirements should be basal insulin 2
- Must use short-acting, premeal insulin to satisfy the remainder of daily insulin requirements 2
- Sliding scale insulin alone should never be used in patients with type 1 diabetes 1
Basal-Bolus Regimen
Dosing Structure:
- For insulin-naive patients or those on low doses: total daily insulin dose between 0.3-0.5 units/kg 1
- Half of total daily insulin dose allocated to basal insulin (1-2 times daily) 1
- Other half allocated to rapid-acting insulin (divided three times daily before meals) 1
- Lower doses for patients with higher hypoglycemia risk (older patients >65 years, renal failure, poor oral intake) 1
For Patients on Higher Insulin Doses:
- For patients treated with higher doses of insulin at home (≥0.6 units/kg/day), reduce total daily insulin dose by 20% while in hospital to prevent hypoglycemia 1
Basal-Plus Approach
- Preferred for patients with mild hyperglycemia, decreased oral intake, or undergoing surgery 1
- Consists of a single dose of basal insulin (0.1-0.25 units/kg/day) 1
- Add corrective doses of insulin for increased glucose before meals or every 6 hours if nil by mouth 1
- Recommended for patients with diabetes who are fasting or expected to undergo procedures 1
Prandial (Bolus) Insulin
- Recommended starting dose: 4 units, 0.1 units/kg, or 10% of the basal dose 1
- If A1C <8% when starting mealtime bolus insulin, consider decreasing the basal insulin dose 1
- Rapid-acting analogs are preferred due to their prompt onset of action 1
- Increase dose by 1-2 units or 10-15% twice weekly based on blood glucose response 1
Important Considerations
Transitioning Between Insulin Regimens:
- When switching from intravenous to subcutaneous insulin, estimate requirements based on the average amount infused during the previous 12 hours 1
- When switching from twice-daily NPH to once-daily glargine, the recommended starting glargine dosage is 80% of the total NPH dosage 2
Avoiding Hypoglycemia:
- The basal-bolus approach is associated with a 4-6 times higher risk of hypoglycemia compared to sliding scale insulin therapy 1
- In controlled settings, the incidence of mild iatrogenic hypoglycemia with basal-bolus is about 12-30% 1
- For patients at high risk of hypoglycemia, consider the basal-plus approach instead of full basal-bolus 1
Regimens to Avoid:
- Premixed insulin therapy (human insulin 70/30) has been associated with an unacceptably high rate of hypoglycemia and is not recommended in the hospital setting 1
- Sliding scale insulin alone is associated with clinically significant hyperglycemia in many patients and its use has been discouraged except in patients without diabetes who have mild stress hyperglycemia 1
Special Situations
For Patients Receiving Enteral Nutrition:
- Use basal insulin (isophane insulin every 8h, detemir every 12h, or glargine every 24h) along with short-acting insulin every 4-6 hours 1
- If tube feeding is interrupted, start intravenous 10% dextrose infusion at 50 mL/h 1
For Patients on Glucocorticoids:
- For patients without diabetes receiving high-dose steroids, a single dose of isophane insulin in the morning might be appropriate 1
- For patients with diabetes on insulin therapy, addition of isophane insulin (0.1-0.3 units/kg/day) to usual insulin regimen can significantly improve glycemic control 1